Kanglexin protects against cardiac fibrosis and dysfunction in mice by TGF-β1/ERK1/2 noncanonical pathway.
Liu X, Han W, An N, Cao N, Wu T, Yang S, Ding L, Chen X, Chen C, Aruhan, Zhang Y, Wang K, Suo L, Huang J, Wang J, Zhao X, Zhu J, Zhang Y, Yang B.
Liu X, et al.
Front Pharmacol. 2021 Jan 14;11:572637. doi: 10.3389/fphar.2020.572637. eCollection 2020.
Front Pharmacol. 2021.
PMID: 33519438
Free PMC article.